Skip NavigationSkip to Content
Return Return to Search Results

Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B approximately FIT Cohort

  1. Author:
    Dallal, C. M.
    Lacey, J. V., Jr.
    Pfeiffer, R. M.
    Bauer, D. C.
    Falk, R. T.
    Buist, D. S.
    Cauley, J. A.
    Hue, T. F.
    LaCroix, A. Z.
    Tice, J. A.
    Veenstra, T. D.
    Xu, X.
    Brinton, L. A.

  2. Author Address

    Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, 20742, USA. cdallal@umd.edu.;Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. cdallal@umd.edu.;Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.;Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Department of Medicine, University of California, San Francisco, CA, USA.;Department of Epidemiology and Biostatistics, University of San Francisco, San Francisco, CA, USA.;Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Group Health Research Institute, Seattle, WA, USA.;Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.;Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, CA, USA.;C2N Diagnostics, Saint Louis, MO, USA.;Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MA, USA.
    1. Year: 2016
    2. Date: Feb
    3. Epub Date: 1/6/2016
  2. Journal: Hormones & Cancer
    1. 7
    2. 1
    3. Pages: 49-64
  4. Type of Article: Article
  5. ISSN: 1868-8497
  1. Abstract:

    Estrogen metabolites may have different genotoxic and mitogenic properties yet their relationship with endometrial and ovarian cancer risk remains unclear. Within the Breast and Bone Follow-up to the Fracture Intervention Trial (B approximately FIT, n = 15,595), we conducted a case-cohort study to evaluate 15 pre-diagnostic serum estrogens and estrogen metabolites with risk of incident endometrial and ovarian cancer among postmenopausal women not on hormone therapy. Participants included 66 endometrial and 67 ovarian cancer cases diagnosed during follow-up ( approximately 10 years) and subcohorts of 346 and 416 women, respectively, after relevant exclusions. Serum concentrations were measured by liquid chromatography-tandem mass spectrometry. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard regression. Exposures were categorized in tertiles (T) and analyzed individually, as metabolic pathways (C-2, -4, or -16) and as ratios to parent estrogens (estradiol, estrone). Estradiol was significantly associated with increased endometrial cancer risk (BMI-adjusted HRT3vsT1 = 4.09, 95% CI 1.70, 9.85; p trend = 0.003). 2-Hydroxyestrone and 16alpha-hydroxyestrone were not associated with endometrial risk after estradiol adjustment (2-OHE1:HRT3vsT1 = 1.97, 95% CI 0.78, 4.94; 16-OHE1:HRT3vsT1 = 1.50, 95% CI 0.65, 3.46; p trend = 0.16 and 0.36, respectively). Ratios of 2- and 4-pathway catechol-to-methylated estrogens remained positively associated with endometrial cancer after BMI or estradiol adjustment (2-pathway catechols-to-methylated: HRT3vsT1 = 4.02, 95% CI 1.60, 10.1; 4-pathway catechols-to-methylated: HRT3vsT1 = 4.59, 95% CI 1.64, 12.9; p trend = 0.002 for both). Estrogens and estrogen metabolites were not associated with ovarian cancer risk; however, larger studies are needed to better evaluate these relationships. Estrogen metabolism may be important in endometrial carcinogenesis, particularly with less extensive methylation of 2- or 4-pathway catechols associated with elevated endometrial cancer risk.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1007/s12672-015-0237-y
  3. PMID: 26728471

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel